These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35861050)

  • 1. Zwitterionic polymer coated sorafenib-loaded Fe
    Lin J; Zhang J; Wang K; Guo S; Yang W
    J Mater Chem B; 2022 Aug; 10(30):5784-5795. PubMed ID: 35861050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy.
    Guan Q; Guo R; Huang S; Zhang F; Liu J; Wang Z; Yang X; Shuai X; Cao Z
    J Control Release; 2020 Apr; 320():392-403. PubMed ID: 32004587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
    Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
    Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy.
    Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W
    Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
    Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
    J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.
    Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ
    ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
    Liu X; Zhu X; Qi X; Meng X; Xu K
    Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells.
    Ou H; Cheng T; Zhang Y; Liu J; Ding Y; Zhen J; Shen W; Xu Y; Yang W; Niu P; Liu J; An Y; Liu Y; Shi L
    Acta Biomater; 2018 Jan; 65():339-348. PubMed ID: 29079515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-based nanoparticles for MR imaging-guided ferroptosis in combination with photodynamic therapy to enhance cancer treatment.
    Chen Q; Ma X; Xie L; Chen W; Xu Z; Song E; Zhu X; Song Y
    Nanoscale; 2021 Mar; 13(9):4855-4870. PubMed ID: 33624647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.
    Hou M; Liu M; Yu H; Kou Y; Jia J; Zhou Q; Zhang F; Zhao D; Zhao T; Li X
    Nano Lett; 2024 Jan; 24(4):1284-1293. PubMed ID: 38230643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment.
    Xue K; Yang R; An Y; Ding Y; Li S; Miao F; Liu D; Chen D; Tang Q
    J Control Release; 2024 Apr; 368():595-606. PubMed ID: 38185333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.
    Xie X; Li Z; Tang H; Zhang Y; Huang Y; Zhang F; You Y; Xu L; Wu C; Yao Z; Peng X; Zhang Q; Li B
    Acta Biomater; 2024 Jul; 183():292-305. PubMed ID: 38838903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fe
    Chen L; Lin Z; Liu L; Zhang X; Shi W; Ge D; Sun Y
    ACS Biomater Sci Eng; 2019 Sep; 5(9):4861-4869. PubMed ID: 33448829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementing Cancer Photodynamic Therapy with Ferroptosis through Iron Oxide Loaded Porphyrin-Grafted Lipid Nanoparticles.
    Liang X; Chen M; Bhattarai P; Hameed S; Tang Y; Dai Z
    ACS Nano; 2021 Dec; 15(12):20164-20180. PubMed ID: 34898184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BHQ-Cyanine-Based "Off-On" Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device.
    Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Liu W
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):42873-42884. PubMed ID: 31553151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis.
    Tang Q; Wang Y; Yan B; Zhang J; Wang T; Fang Y; Ye Z; Zhang N; Zhang N; Wu Z; Fan H; Lyu Y; Liu X; Wu R
    ACS Nano; 2024 Oct; 18(43):29804-29819. PubMed ID: 39431335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Responsive multifunctional "core-shell" magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy.
    Chi H; Zhu G; Yin Y; Diao H; Liu Z; Sun S; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
    Int J Pharm; 2022 Jun; 622():121898. PubMed ID: 35688287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biomimetic nanodrug self-assembled from small molecules for enhanced ferroptosis therapy.
    Xu X; Chen Y; Gui J; Liu P; Huang Y; Shao B; Ping Y; Li B
    Biomater Sci; 2022 Feb; 10(3):770-780. PubMed ID: 34988569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
    Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
    J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intelligent Size-Switchable Iron Carbide-Based Nanocapsules with Cascade Delivery Capacity for Hyperthermia-Enhanced Deep Tumor Ferroptosis.
    Wang J; Fang Z; Zhao C; Sun Z; Gao S; Zhang B; Qiu D; Yang M; Sheng F; Gao S; Hou Y
    Adv Mater; 2024 Mar; 36(9):e2307006. PubMed ID: 37924225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.